Talis Biomedical Corporation
TLIS · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62 | -$113 | -$192 | -$91 |
| Dep. & Amort. | $1 | $9 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $5 | $9 | $4 |
| Change in WC | -$3 | -$8 | $9 | -$1 |
| Other Non-Cash | $7 | $6 | $1 | $1 |
| Operating Cash Flow | -$53 | -$100 | -$171 | -$87 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$3 | -$8 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$2 | -$3 | -$8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $233 | $247 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $2 | $247 |
| Financing Cash Flow | $0 | $0 | $234 | $247 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$54 | -$101 | $60 | $152 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $132 | $233 | $173 | $22 |
| End Cash | $78 | $132 | $233 | $173 |
| Free Cash Flow | -$54 | -$102 | -$174 | -$95 |